Short-term Effects of High-Dose Caffeine on Cardiac Arrhythmias in Patients With Heart Failure: A Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
IMPORTANCE: The presumed proarrhythmic action of caffeine is controversial. Few studies have assessed the effect of high doses of caffeine in patients with heart failure due to left ventricular systolic dysfunction at high risk for ventricular arrhythmias. OBJECTIVE: To compare the effect of high-dose caffeine or placebo on the frequency of supraventricular and ventricular arrhythmias, both at rest and during a symptom-limited exercise test. DESIGN, SETTING, AND PARTICIPANTS: Double-blinded randomized clinical trial with a crossover design conducted at the heart failure and cardiac transplant clinic of a tertiary-care university hospital. The trial included patients with chronic heart failure with moderate-to-severe systolic dysfunction (left ventricular ejection fraction <45%) and New York Heart Association functional class I to III between March 5, 2013, and October 2, 2015. INTERVENTIONS: Caffeine (100 mg) or lactose capsules, in addition to 5 doses of 100 mL decaffeinated coffee at 1-hour intervals, for a total of 500 mg of caffeine or placebo during a 5-hour protocol. After a 1-week washout period, the protocol was repeated. MAIN OUTCOMES AND MEASURES: Number and percentage of ventricular and supraventricular premature beats assessed by continuous electrocardiographic monitoring. RESULTS: We enrolled 51 patients (37 [74%] male; mean [SD] age, 60.6 [10.9] years) with predominantly moderate-to-severe left ventricular systolic dysfunction (mean [SD] left ventricular ejection fraction, 29% [7%]); 31 [61%] had an implantable cardioverter-defibrillator device. No significant differences between the caffeine and placebo groups were observed in the number of ventricular (185 vs 239 beats, respectively; P = .47) and supraventricular premature beats (6 vs 6 beats, respectively; P = .44), as well as in couplets, bigeminal cycles, or nonsustained tachycardia during continuous electrocardiographic monitoring. Exercise test-derived variables, such as ventricular and supraventricular premature beats, duration of exercise, estimated peak oxygen consumption, and heart rate, were not influenced by caffeine ingestion. We observed no increases in ventricular premature beats (91 vs 223 vs 207 beats, respectively) in patients with higher levels of plasma caffeine concentration compared with lower plasma levels (P = .91) or with the placebo group (P = .74). CONCLUSIONS AND RELEVANCE: Acute ingestion of high doses of caffeine did not induce arrhythmias in patients with systolic heart failure and at high risk for ventricular arrhythmias. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02045992.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00232 · Cited by 3,824
Coffee and Health: A Review of Recent Human Research
Higdon, J. V., & Frei, B. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390500400009 · Cited by 1,090
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
Schulz, K. F., Altman, D. G., & Moher, D. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00017 · Cited by 259
Absorption and subjective effects of caffeine from coffee, cola and capsules
Liguori, A. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00003-8 · Cited by 189
Habitual Coffee Consumption and Risk of Heart Failure: A Dose-Response Meta-Analysis
Mostofsky, E., Rice, M. S., Levitan, E. B., & Mittleman, M. A. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.967299 · Cited by 185
Fatal Caffeine Overdose: A Case Report and Review of Literature
Jabbar, S. B., & Hanly, M. G. (2013) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000000058 · Cited by 82
Cited by
Caffeine and cardiovascular health
Turnbull, D., Rodricks, J. V., Mariano, G. F., & Chowdhury, F. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.07.025 · Cited by 216
Benjamim, C. J. R., Kliszczewicz, B., Garner, D. M., Cavalcante, T. C. F., da Silva, A. A. M., Santana, M. D. R., & Valenti, V. E. (2020) · Journal of the American College of Nutrition · doi:10.1080/07315724.2019.1705201 · Cited by 39
Sampaio-Jorge, F., Morales, A. P., Pereira, R., Barth, T., & Ribeiro, B. G. (2021) · Scientific Reports · doi:10.1038/s41598-021-03158-2 · Cited by 15
Metadata
- Authors
- Zuchinali, P., Souza, G. C., Pimentel, M., Chemello, D., Zimerman, A., Giaretta, V., Salamoni, J., Fracasso, B., Zimerman, L. I., & Rohde, L. E.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2016-12-01
- Volume
- 176
- Issue
- 12
- Pages
- 1752
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W2532009223
- Cited by
- 43
- References
- 6
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Short-term Effects of High-Dose Caffeine on Cardiac Arrhythmias in Patients With Heart Failure: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jamainternmed.2016.6374
- The paper
- Zuchinali, P., Souza, G. C., Pimentel, M., Chemello, D., Zimerman, A., Giaretta, V., Salamoni, J., Fracasso, B., Zimerman, L. I., & Rohde, L. E. (2016). Short-term Effects of High-Dose Caffeine on Cardiac Arrhythmias in Patients With Heart Failure: A Randomized Clinical Trial. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2016.6374
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.